MA27172A1 - 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments - Google Patents

3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments

Info

Publication number
MA27172A1
MA27172A1 MA27803A MA27803A MA27172A1 MA 27172 A1 MA27172 A1 MA 27172A1 MA 27803 A MA27803 A MA 27803A MA 27803 A MA27803 A MA 27803A MA 27172 A1 MA27172 A1 MA 27172A1
Authority
MA
Morocco
Prior art keywords
oxdiazol
alcoxy
medicines
phenyl
production
Prior art date
Application number
MA27803A
Other languages
English (en)
Inventor
Karl Schoenafinger
Stefan Petry
Gunter Muller
Armin Bauer
Hubert Ott Heuer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MA27172A1 publication Critical patent/MA27172A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
MA27803A 2002-02-28 2004-07-27 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments MA27172A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (de) 2002-02-28 2002-02-28 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen

Publications (1)

Publication Number Publication Date
MA27172A1 true MA27172A1 (fr) 2005-01-03

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27803A MA27172A1 (fr) 2002-02-28 2004-07-27 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments

Country Status (22)

Country Link
EP (1) EP1480960B1 (fr)
JP (1) JP4486363B2 (fr)
KR (1) KR20040095240A (fr)
CN (1) CN1639137A (fr)
AR (1) AR038701A1 (fr)
AT (1) ATE557012T1 (fr)
AU (1) AU2003226977A1 (fr)
BR (1) BR0307921A (fr)
CA (1) CA2477031A1 (fr)
CO (1) CO5611146A2 (fr)
DE (1) DE10208987A1 (fr)
HR (1) HRP20040782A2 (fr)
HU (1) HUP0402671A3 (fr)
IL (1) IL163683A0 (fr)
MA (1) MA27172A1 (fr)
MX (1) MXPA04007960A (fr)
NO (1) NO20044090L (fr)
PE (1) PE20030928A1 (fr)
PL (1) PL370423A1 (fr)
RU (1) RU2004128933A (fr)
TW (1) TW200400951A (fr)
WO (1) WO2003072555A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
WO2006045799A2 (fr) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Compositions pharmaceutiques contenant des antagonistes des recepteurs cannabinoides et des agents d'ouverture de canaux potassiques dans le traitement du diabete insulino-dependant, de l'obesite et des etats associes
CN101959881A (zh) * 2007-12-27 2011-01-26 比艾尔-坡特拉有限公司 用于医疗用途的5-o-取代3-n-苯基-1,3,4-噁二唑酮
TW201028406A (en) 2008-12-23 2010-08-01 Bial Portela & Ca Sa 5-O-substituted 3-N-aryl-1,3,4-oxadiazolones for medical use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
CN1261419C (zh) * 2000-03-07 2006-06-28 萨诺费－阿文蒂斯德国有限公司 取代的3－苯基－5－烷氧基－1,3,4－噁二唑－2－酮及其抑制激素敏感性脂酶的用途

Also Published As

Publication number Publication date
TW200400951A (en) 2004-01-16
AU2003226977A1 (en) 2003-09-09
NO20044090L (no) 2004-11-04
IL163683A0 (en) 2005-12-18
EP1480960A1 (fr) 2004-12-01
ATE557012T1 (de) 2012-05-15
PE20030928A1 (es) 2003-12-17
AR038701A1 (es) 2005-01-26
HUP0402671A3 (en) 2006-07-28
PL370423A1 (en) 2005-05-30
HUP0402671A2 (hu) 2005-04-28
JP4486363B2 (ja) 2010-06-23
CN1639137A (zh) 2005-07-13
JP2005519085A (ja) 2005-06-30
WO2003072555A1 (fr) 2003-09-04
KR20040095240A (ko) 2004-11-12
EP1480960B1 (fr) 2012-05-09
HRP20040782A2 (en) 2005-02-28
DE10208987A1 (de) 2003-09-11
RU2004128933A (ru) 2005-04-20
BR0307921A (pt) 2004-12-21
CA2477031A1 (fr) 2003-09-04
MXPA04007960A (es) 2004-11-26
CO5611146A2 (es) 2006-02-28

Similar Documents

Publication Publication Date Title
PT1095025E (pt) Benzimidazoles sua producao e sua utilizacao como medicamentos
DE60328481D1 (de) Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält
PL1667993T3 (pl) Heteroarylo-podstawione pochodne 1,3-dihydroindol-2-onu i zawierające je leki
SI1532149T1 (sl) amino piperidin il ksantini njihova priprava in njihova uporaba kot zdravila
ATE432919T1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
AU2003292239A1 (en) Novel carboxamides, the production and use thereof as medicaments
SI1562946T1 (sl) Novi ksantinski derivati njihova priprava in njihova uporaba kot zdravila
IL213597A0 (en) Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IS7564A (is) Lyfjablanda með breytta losun
DE602004025165D1 (de) Endgerät mit Halt-/Fortsetzungsfunktion und dazugehöriges Computerprogrammprodukt
ZA200604432B (en) Thiozolidinones production and use thereof as medicaments
HK1081554A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
IL138702A0 (en) Substituted indolinones, the production thereof and their use as medicaments
PT1500654E (pt) Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos
EE200300193A (et) Asendatud bensimidasoolid, nende kasutamine ja ravim
PL354533A1 (en) Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
MA27172A1 (fr) 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments
FR2870539B1 (fr) Nouvelles methodes et medicaments
ATE487741T1 (de) Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten
AU2003254556A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
PT1235809E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocinas substituidas e sua utilizacao como medicamentos
PT1496884E (pt) Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas.